Related Experiment Video
Updated: Dec 13, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Comorbidity indices in people with HIV and considerations for coronavirus disease 2019 outcomes
Alan Winston1,2, Davide De Francesco3, Frank Post4
1Department of Infectious Disease, Faculty of Medicine, Imperial College London.
Insights
People with HIV (PWH) have higher comorbidity indices than HIV-negative individuals, though the differences are small. The Elixhauser Comorbidity Index was higher in PWH, potentially impacting COVID-19 outcomes.
Area of Science:
- Medical research
- Public health
- Epidemiology
Background:
- HIV infection can affect long-term health and increase the risk of comorbidities.
- Understanding comorbidity burden in people with HIV (PWH) is crucial for comprehensive care.
- Previous studies suggest PWH may experience accelerated aging and increased non-AIDS-related conditions.
Purpose of the Study:
- To compare comorbidity indices between people with HIV (PWH) and similar HIV-negative controls.
- To assess the magnitude of differences in comorbidity burden using established indices.
Main Methods:
- Cross-sectional analysis of the "Pharmacokinetic and clinical Observations in PeoPle over fiftY" cohort.
- Comparison of Elixhauser Comorbidity Index (ECI), Charlson Comorbidity Index, and Comorbidity Burden Index between PWH and controls.
- Statistical analysis using Mann-Whitney U test and effect size calculation.
Main Results:
- The study included 699 PWH and 304 HIV-negative controls, predominantly male and white.
- All three comorbidity indices were significantly higher in PWH compared to controls (P < 0.001).
- Effect sizes for the differences were small to medium, ranging from 0.18 to 0.38.
Conclusions:
- People with HIV (PWH) exhibit higher comorbidity indices than HIV-negative controls.
- The observed differences, while statistically significant, were of small to medium magnitude.
- Elevated ECI in PWH may be linked to increased prevalence at the higher end of the index range, potentially influencing outcomes like COVID-19.
Objective:
To determine comorbidity indices in people with HIV (PWH) and lifestyle-similar HIV-negative controls.
Design:
Cross-sectional analysis of the Pharmacokinetic and clinical Observations in PeoPle over fiftY cohort study in the United Kingdom and Ireland.
Methods:
The Elixhauser Comorbidity Index (ECI), Charlson Comorbidity Index and the Comorbidity Burden Index were compared between older PWH and HIV-negative controls using the Mann-Whitney U test; the magnitude of the difference between groups was quantified using the r effect size.
Results:
The 699 PWH and 304 HIV-negative controls were predominantly male (87.5% vs. 64.0%), white (86.3% vs. 90.0%) and had median ages of 57 and 58 years, respectively. Among PWH, the median (interquartile range) CD4 T-cell count was 624 (475, 811) cells/μl; 98.7% were on antiretroviral therapy. The median (interquartile range) ECI was 0 (0, 8) and 0 (-3, 1), Charlson Comorbidity Index was 2 (1, 5) and 1 (0, 1) and Comorbidity Burden Index 8.6 (2.2, 16.8) and 5.9 (0.6, 10.8), respectively. While all three indices were significantly higher in PWH than in controls (P < 0.001 for each), the magnitude of the differences between the two groups were small to medium, with effect sizes (95% confidence interval) of 0.21 (0.16, 0.27), 0.38 (0.32, 0.42) and 0.18 (0.11, 0.23), respectively.
Conclusion:
These three comorbidity indices are higher in PWH compared with HIV-negative controls, although the magnitude of differences between groups were small. Differences in the ECI, reportedly associated with poorer coronavirus disease 2019 outcomes, were driven by more individuals with HIV being within the higher end of the range.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Pneumonia III: Complications and Assessment
Coronary Artery Disease III: Clinical Manifestations
Sexually Transmitted Infections
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...

